GNBT - Generex biotechnology and Oral-Lyn

Generex Biotechnology Announces New Oral Insulin Clinical Data :

The study compared the effects of two forms of prandial (mealtime) insulin in patients with Type-1 diabetes mellitus maintained on basal isophane insulin (NPH): Generex Oral-lyn versus pre-prandial subcutaneous injections of regular bolus insulin. ...

The study demonstrated that both Generex Oral-lyn and mealtime injections of regular insulin achieved near normalization of metabolic control parameters as reflected by continuous improvement in fructosamine and HbA1c concentrations. In fact, a straightforward comparison of HbA1c during the comparison phase showed a superior effect for Generex Oral-lyn. By providing a safe, simple, fast, flexible, familiar, and effective alternative to mealtime insulin injections, Generex Oral-lyn is designed to improve patient compliance which promotes metabolic stability which in turn delays the onset and reduces the severity of the complications associated with diabetes.

Yes, I own stock: got in at an average price of somewhere around $2.- or so. Really, I just wanted to highlight some good news: here's a product that could help improve the quality of life for many diabetes patients. Imagine simply inhaling insulin with a device similar to asthma inhalers instead of injecting insulin. Good stuff here.